O31: (3aR,7S,10S,12R,21E,24aR)-7-tert-butyl-N-[(1R,2R)-2-(difluoromethyl)-1-{[(1-methylcyclopropyl)sulfonyl]carbamoyl}cyclop
ropyl]-20,20-difluoro-5,8-dioxo-2,3,3a,5,6,7,8,11,12,20,23,24a-dodecahydro-1H,10H-9,12-methanocyclopenta[18,19][1,10,17,
3,6]trioxadiazacyclononadecino[11,12-b]quinoxaline-10-carboxamide
O31 is a Ligand Of Interest in 6P6M designated by the Author
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with same target (top 5) |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|
| 6P6M_O31_A_1301 | 67% | 5% | 0.123 | 0.931 | 3.26 | 2.15 | 20 | 22 | 0 | 0 | 100% | 1 |
| 6P6L_O31_A_1208 | 90% | 11% | 0.083 | 0.966 | 2.16 | 1.99 | 17 | 18 | 0 | 0 | 100% | 1 |
| 6P6R_O31_A_1206 | 89% | 8% | 0.083 | 0.961 | 2.73 | 1.95 | 17 | 19 | 0 | 0 | 100% | 1 |
| 6P6O_O31_A_1202 | 65% | 5% | 0.132 | 0.934 | 3.22 | 2.11 | 20 | 20 | 0 | 0 | 100% | 1 |
| 6P6T_O31_A_1202 | 80% | 6% | 0.113 | 0.963 | 3.19 | 1.97 | 20 | 16 | 0 | 0 | 100% | 1 |
| 6P6S_O31_A_1201 | 80% | 7% | 0.11 | 0.958 | 3.05 | 1.82 | 18 | 20 | 0 | 0 | 100% | 1 |
| 6P6Z_O31_A_1202 | 73% | 5% | 0.122 | 0.949 | 3.28 | 2.11 | 21 | 19 | 0 | 0 | 100% | 1 |
